Cargando…

Withania somnifera phytochemicals possess SARS-CoV-2 RdRp and human TMPRSS2 protein binding potential

ABSTRACT: Coronavirus disease-19 (COVID-19) pandemic caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) has infected approximately 26 million people and caused more than 6 million deaths globally. Spike (S)-protein on the outer surface of the virus uses human trans-membrane serin...

Descripción completa

Detalles Bibliográficos
Autores principales: Prajapati, Kumari Sunita, Singh, Atul Kumar, Kushwaha, Prem Prakash, Shuaib, Mohd, Maurya, Santosh Kumar, Gupta, Sanjay, Senapati, Sabyasachi, Singh, Surya Pratap, Waseem, Mohammad, Kumar, Shashank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199469/
https://www.ncbi.nlm.nih.gov/pubmed/35729946
http://dx.doi.org/10.1007/s42535-022-00404-4
_version_ 1784727845013028864
author Prajapati, Kumari Sunita
Singh, Atul Kumar
Kushwaha, Prem Prakash
Shuaib, Mohd
Maurya, Santosh Kumar
Gupta, Sanjay
Senapati, Sabyasachi
Singh, Surya Pratap
Waseem, Mohammad
Kumar, Shashank
author_facet Prajapati, Kumari Sunita
Singh, Atul Kumar
Kushwaha, Prem Prakash
Shuaib, Mohd
Maurya, Santosh Kumar
Gupta, Sanjay
Senapati, Sabyasachi
Singh, Surya Pratap
Waseem, Mohammad
Kumar, Shashank
author_sort Prajapati, Kumari Sunita
collection PubMed
description ABSTRACT: Coronavirus disease-19 (COVID-19) pandemic caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) has infected approximately 26 million people and caused more than 6 million deaths globally. Spike (S)-protein on the outer surface of the virus uses human trans-membrane serine protease-2 (TMPRSS2) to gain entry into the cell. Recent reports indicate that human dipeptidyl peptidase-4 inhibitors (DPP4 or CD26) could also be utilized to check the S-protein mediated viral entry into COVID-19 patients. RNA dependent RNA polymerase (RdRp) is another key virulence protein of SARS-CoV-2 life cycle. The study aimed to identify the potential anti-SARS-CoV-2 inhibitors present in Withania somnifera (Solanaceae) using computer aided drug discovery approach. Molecular docking results showed that flavone glycoside, sugar alcohol, and flavonoid present in W. somnifera showed − 11.69, − 11.61, − 10.1, − 7.71 kcal/mole binding potential against S-protein, CD26, RdRp, and TMPRSS2 proteins. The major standard inhibitors of the targeted proteins (Sitagliptin, VE607, Camostat mesylate, and Remdesivir) showed the − 7.181, − 6.6, − 5.146, and − 7.56 kcal/mole binding potential. Furthermore, the lead phytochemicals and standard inhibitors bound and non-bound RdRp and TMPRSS2 proteins were subjected to molecular dynamics (MD) simulation to study the complex stability and change in protein conformation. The result showed energetically favorable and stable complex formation in terms of RMSD, RMSF, SASA, Rg, and hydrogen bond formation. Drug likeness and physiochemical properties of the test compounds exhibited satisfactory results. Taken together, the present study suggests the presence of potential anti-SARS-CoV-2 phytochemicals in W. somnifera that requires further validation in in vitro and in vivo studies. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s42535-022-00404-4.
format Online
Article
Text
id pubmed-9199469
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Nature Singapore
record_format MEDLINE/PubMed
spelling pubmed-91994692022-06-17 Withania somnifera phytochemicals possess SARS-CoV-2 RdRp and human TMPRSS2 protein binding potential Prajapati, Kumari Sunita Singh, Atul Kumar Kushwaha, Prem Prakash Shuaib, Mohd Maurya, Santosh Kumar Gupta, Sanjay Senapati, Sabyasachi Singh, Surya Pratap Waseem, Mohammad Kumar, Shashank Vegetos Research Articles ABSTRACT: Coronavirus disease-19 (COVID-19) pandemic caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) has infected approximately 26 million people and caused more than 6 million deaths globally. Spike (S)-protein on the outer surface of the virus uses human trans-membrane serine protease-2 (TMPRSS2) to gain entry into the cell. Recent reports indicate that human dipeptidyl peptidase-4 inhibitors (DPP4 or CD26) could also be utilized to check the S-protein mediated viral entry into COVID-19 patients. RNA dependent RNA polymerase (RdRp) is another key virulence protein of SARS-CoV-2 life cycle. The study aimed to identify the potential anti-SARS-CoV-2 inhibitors present in Withania somnifera (Solanaceae) using computer aided drug discovery approach. Molecular docking results showed that flavone glycoside, sugar alcohol, and flavonoid present in W. somnifera showed − 11.69, − 11.61, − 10.1, − 7.71 kcal/mole binding potential against S-protein, CD26, RdRp, and TMPRSS2 proteins. The major standard inhibitors of the targeted proteins (Sitagliptin, VE607, Camostat mesylate, and Remdesivir) showed the − 7.181, − 6.6, − 5.146, and − 7.56 kcal/mole binding potential. Furthermore, the lead phytochemicals and standard inhibitors bound and non-bound RdRp and TMPRSS2 proteins were subjected to molecular dynamics (MD) simulation to study the complex stability and change in protein conformation. The result showed energetically favorable and stable complex formation in terms of RMSD, RMSF, SASA, Rg, and hydrogen bond formation. Drug likeness and physiochemical properties of the test compounds exhibited satisfactory results. Taken together, the present study suggests the presence of potential anti-SARS-CoV-2 phytochemicals in W. somnifera that requires further validation in in vitro and in vivo studies. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s42535-022-00404-4. Springer Nature Singapore 2022-06-15 2023 /pmc/articles/PMC9199469/ /pubmed/35729946 http://dx.doi.org/10.1007/s42535-022-00404-4 Text en © The Author(s) under exclusive licence to Society for Plant Research 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Research Articles
Prajapati, Kumari Sunita
Singh, Atul Kumar
Kushwaha, Prem Prakash
Shuaib, Mohd
Maurya, Santosh Kumar
Gupta, Sanjay
Senapati, Sabyasachi
Singh, Surya Pratap
Waseem, Mohammad
Kumar, Shashank
Withania somnifera phytochemicals possess SARS-CoV-2 RdRp and human TMPRSS2 protein binding potential
title Withania somnifera phytochemicals possess SARS-CoV-2 RdRp and human TMPRSS2 protein binding potential
title_full Withania somnifera phytochemicals possess SARS-CoV-2 RdRp and human TMPRSS2 protein binding potential
title_fullStr Withania somnifera phytochemicals possess SARS-CoV-2 RdRp and human TMPRSS2 protein binding potential
title_full_unstemmed Withania somnifera phytochemicals possess SARS-CoV-2 RdRp and human TMPRSS2 protein binding potential
title_short Withania somnifera phytochemicals possess SARS-CoV-2 RdRp and human TMPRSS2 protein binding potential
title_sort withania somnifera phytochemicals possess sars-cov-2 rdrp and human tmprss2 protein binding potential
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199469/
https://www.ncbi.nlm.nih.gov/pubmed/35729946
http://dx.doi.org/10.1007/s42535-022-00404-4
work_keys_str_mv AT prajapatikumarisunita withaniasomniferaphytochemicalspossesssarscov2rdrpandhumantmprss2proteinbindingpotential
AT singhatulkumar withaniasomniferaphytochemicalspossesssarscov2rdrpandhumantmprss2proteinbindingpotential
AT kushwahapremprakash withaniasomniferaphytochemicalspossesssarscov2rdrpandhumantmprss2proteinbindingpotential
AT shuaibmohd withaniasomniferaphytochemicalspossesssarscov2rdrpandhumantmprss2proteinbindingpotential
AT mauryasantoshkumar withaniasomniferaphytochemicalspossesssarscov2rdrpandhumantmprss2proteinbindingpotential
AT guptasanjay withaniasomniferaphytochemicalspossesssarscov2rdrpandhumantmprss2proteinbindingpotential
AT senapatisabyasachi withaniasomniferaphytochemicalspossesssarscov2rdrpandhumantmprss2proteinbindingpotential
AT singhsuryapratap withaniasomniferaphytochemicalspossesssarscov2rdrpandhumantmprss2proteinbindingpotential
AT waseemmohammad withaniasomniferaphytochemicalspossesssarscov2rdrpandhumantmprss2proteinbindingpotential
AT kumarshashank withaniasomniferaphytochemicalspossesssarscov2rdrpandhumantmprss2proteinbindingpotential